Live Rate
| Open | |
|---|---|
| High | |
| Low | |
| Prev. Close | |
| Lower circuit | |
| Upper circuit | |
| 52w High | |
| 52w Low | |
| P/E Ratio |
Anondita Medicare Listing Price
| Exchange | Listing Price | Gain/Loss | % |
|---|---|---|---|
| NSE | ₹275.00 | +₹130.00 | +89.66% |
Anondita Medicare Subscription
Last updated on 26-Aug-2025 18:33:02
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIB | 906000 | 138648000 | 153.03 |
| HNIs | 681000 | 362193000 | 531.85 |
| bHNI | 454000 | 291023000 | 641.02 |
| sHNI | 227000 | 71170000 | 313.52 |
| Individual | 1586000 | 454242000 | 286.41 |
| Total | 3173000 | 955083000 | 301 |
Application-Wise Breakup  | |||
|---|---|---|---|
| Category | Reserved | Applied | Times |
| HNIs (10L+) | 151 | 38388 | 254.23 |
| HNIs (3-10L) | 76 | 22530 | 296.45 |
| Individual | 793 | 227121 | 286.41 |
| Subscription Demand (in ₹ crore) | |||
|---|---|---|---|
| Category | Offered | Demand | Times |
| QIB | 13.14 | 2010.4 | 153.03 |
| FII | - | 504.25 | - |
| FI | - | 138.01 | - |
| IC | - | 26.03 | - |
| MF | - | 7.09 | - |
| OTH | - | 1335.02 | - |
| HNIs | 9.87 | 5251.8 | 531.85 |
| bHNI | 6.58 | 4219.83 | 641.02 |
| sHNI | 3.29 | 1031.97 | 313.52 |
| Individual | 23 | 6586.51 | 286.41 |
| Total | 46.01 | 13848.7 | 301 |
| QIB Interest Cost Per Share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹29.8 | @8% ₹34 | @9% ₹38.3 | @10% ₹42.6 | @11% ₹46.8 | @12% ₹51.1 |
Anondita Medicare Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| bHNI | 7 | 7000 | 1015000 | 151 |
Anondita Medicare Reservation
| Category | Shares Offered | % |
|---|---|---|
| Anchor | 1350000 | 28.17% |
| QIB | 906000 | 18.9% |
| HNI | 681000 | 14.21% |
| INDIVIDUAL | 1586000 | 33.09% |
| Market Maker | 270000 | 5.63% |
| Total | 4793000 | 100% |
Anondita Medicare About
Anondita Medicare IPO Details
| Total Issue Size | 47,93,000 shares (aggregating up to 69.50 Cr) |
| Fresh Issue | 47,93,000 shares (aggregating up to 69.50 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,32,93,618 shares |
| Share Holding Post Issue | 1,80,86,618 shares |
| Reserved for Market Maker | 2,70,000 shares (aggregating up to ₹3.92 Cr) |
| Market Maker | Mansi Share & Stock Broking Pvt.Ltd. |
Key Performance Indicator (KPI)
| KPI | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| ROE | 41.71% | 36.31% | 3.99% |
| RONW | 41.71% | 36.31% | 3.99% |
| EPS (basic) | 14.04 | - | - |
| P/E Pre IPO | 11.74 | ||
| P/E Post IPO | 15.98 |
Financial Details In Crores
| Period Ended | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| Assets | 78.27 | 42.92 | 37.8 |
| Total Income | 77.13 | 46.56 | 36.14 |
| Profit After Tax | 16.42 | 3.84 | 0.35 |
| EBITDA | 25.65 | 9.09 | 3.58 |
| Net Worth | 37.87 | 10.59 | 8.69 |
| Reserves and Surplus | 24.58 | 10.39 | 6.55 |
| Total Borrowing | 27.39 | 24.01 | 22.66 |
Peer Comparision (Valuation)
| Company | P/E (x) | CMP*(₹) | Face value (₹) |
|---|---|---|---|
| Anondita Medicare Limited | - | - | 10 |
| Cupid Limited | 110.38 | 167.78 | 1 |
Sourced from Annual Reports, Audited and Unaudited Financials, BSE. Current Market Price is taken as closing on August 14, 2025. The P/E Ratio is as on August 14, 2025.
Peer Comparison (Financial Performance)
| Company | NAV/Share (₹) | RoNW (%) | EPS (Basic) (₹) |
|---|---|---|---|
| Anondita Medicare Limited | 21.32 | 38.10 | 9.6 |
| Cupid Limited | 12.75 | 11.96 | 1.52 |
About Company
Founded: March 2024
Core Business: Manufactures flavored male condoms under the brand "COBRA".
Production Capacity: 56.2 crore condoms annually (562 million).
Headquarters & Facility: Noida, Uttar Pradesh, India.
Market Reach
Exports: Southeast Asia, Africa, and the Middle East.
Distribution: Strong network via wholesalers, retailers, e-commerce, and government health programs.
Partnerships: Collaborates with global NGOs, health organizations, and governments for family planning initiatives.
IPO Objectives (Fund Utilization)
The company aims to raise funds for:
Capital Expenditure: ₹6 crores for machinery/equipment.
Working Capital: ₹35 crores to support operations.
General Corporate Purposes: Unspecified amount for acquisitions/other needs.
Strength
Market Leadership – Strong presence in North India with recognized brand value.
Product Innovation – Wide portfolio including flavored and specialty condoms.
Robust Distribution – Well-established domestic and international supply chain.
Weakness
Negative Cash Flows – Past and potential future negative cash flows may strain growth and operations.
Customer Concentration – Heavy reliance on top 10 customers increases revenue vulnerability.
Government Tender Dependence – Significant reliance on government contracts exposes the business to regulatory and compliance risks.
Anondita Medicare Latest Announcements
| Date | Subject | Attachment Text |
|---|
Anondita Medicare Financial Results
Anondita Medicare Lead Manager(s)
Anondita Medicare Address
Flat No.704 Narmada Block,
N6, Sec-D
Pkt-6 Vasant Kunj,
New Delhi, New Delhi, 110070
Phone: 0120-4520300
Email: info@anonditamedicare.com
Website: https://anonditamedicare.com/